권호기사보기
기사명 | 저자명 | 페이지 | 원문 | 기사목차 |
---|
대표형(전거형, Authority) | 생물정보 | 이형(異形, Variant) | 소속 | 직위 | 직업 | 활동분야 | 주기 | 서지 | |
---|---|---|---|---|---|---|---|---|---|
연구/단체명을 입력해주세요. |
|
|
|
|
|
* 주제를 선택하시면 검색 상세로 이동합니다.
목적: 정상안압녹내장 환자에서 tafluporst 0.0015%와 timolol 0.5% 혼합제제(Tapcom®, Santen, Osaka, Japan)의 안압하강 효과에 대해 알아보고자 한다.
대상과 방법: Tafluprost 0.0015%와 timolol 0.5% 혼합제제를 사용하고 있는 정상안압녹내장 환자 23명을 대상으로 혼합제제를 사용하기 전 오전 9시부터 오후 4시 30분까지 2시간 30분 간격으로 하루 안압을 측정하고, 오후 4시 30분에 자세별 안압을 측정하였으며, 혼합제제를 6개월간 사용한 후 하루 안압 및 자세별 안압을 다시 측정하여 안압하강 효과에 대해 분석하였다.
결과: 6개월간 tafluprost 0.0015%-timolol 0.5% 혼합제제 점안 후 안압하강 효과는 우안 -3.37 ± 2.39 mmHg (-19.70 ± 13.97%), 좌안 -3.22 ± 2.27 mmHg (-18.81 ± 13.28%)로 통계적으로 유의한 감소를 보였으며, 오후 4시 30분에 측정한 자세별 안압에서 치료전과 비교하여 양안 모두 통계적으로 유의한 하강을 보였다. 점안안에서 하루 안압의 변동 양상은 변동량이 3 mmHg 이하인 군의비율이 6개월간 혼합제제 점안 후 통계적으로 유의하게 증가하였으며, 안압하강 효과는 혼합제제 점안 후 처음 1개월 동안 가장 크게 나타났고, 안과적 손상을 유발할 만한 심각한 부작용은 나타나지 않았다.
결론: 녹내장 환자에서 tafluprost 0.0015%-timolol 0.5% 혼합제제는 안전하며 안압을 하강시키고, 안정적으로 유지시키는 데 효과적이다.
Purpose: This study evaluated the effect of a fixed combination of 0.0015% tafluprost-0.5% timolol (Tapcom®, Santen, Osaka, Japan) in glaucoma patients.
Methods: This study included 23 patients who were diagnosed with normal tension glaucoma and treated with a fixed combination of 0.0015% tafluprost-0.5% timolol as the first therapy. Diurnal intraocular pressure (IOP) was measured every 2 and 0.5 hours between 9:00 am and 4:30 pm. The IOP change with respect to body position (positional IOP) was measured at baseline and at 6 months after eye-drop instillations. IOP fluctuation was defined as the standard deviation of IOP measurements. Throughout the study, all side effects were recorded and monitored by the investigators.
Results: The mean reduction in IOP in the 0.0015% tafluprost-0.5% timolol fixed combination-treated eyes was -3.37 ± 2.39 mmHg (-19.70 ± 13.97%) for the right eye and -3.22 ± 2.27 mmHg (-18.81 ± 13.28%) for the left eye (paired t-test, p < 0.001). The mean positional IOP measured at 4 pm at 6 months after 0.0015% tafluprost-0.5% timolol fixed combination instillation showed statistically significant reduction from the mean positional IOP at baseline. There was a significant difference in the number of patients with ≤3 mmHg IOP variation over four time points between baseline and at 6 months in the 0.0015% tafluprost-0.5% timolol fixed combination-treated eyes (McNemar test, p < 0.001). There was no serious adverse event causing ocular damage.
Conclusions: Use of 0.0015% tafluprost-0.5% timolol fixed combination was effective and well tolerated in reducing IOP and in maintaining its effectiveness in glaucoma patients.번호 | 참고문헌 | 국회도서관 소장유무 |
---|---|---|
1 | Schulzer M. Intraocular pressure reduction in normal-tension glaucoma patients. The Normal Tension Glaucoma Study Group. Ophthalmology 1992;99:1468-70. | 미소장 |
2 | Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. ![]() |
미소장 |
3 | Discussion ![]() |
미소장 |
4 | Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery ![]() |
미소장 |
5 | Satisfaction and compliance of ocular hypertensive and glaucoma patients topically treated with a combination therapy ![]() |
미소장 |
6 | Prevalence of Primary Open-Angle Glaucoma in Central South Korea: The Namil Study ![]() |
미소장 |
7 | Prevalence, Awareness, and Risk Factors of Primary Open-Angle Glaucoma: Korea National Health and Nutrition Examination Survey 2008–2011 ![]() |
미소장 |
8 | Pfeiffer N, Traverso CE, Lorenz K, et al. A 6-month study comparing efficacy, safety, and tolerability of the preservativefree fixed combination of tafluprost 0.0015% and timolol 0.5% versus each of its individual preservative-free components. Adv Ther 2014;31: 1228-46. | 미소장 |
9 | Hollo G, Hommer A, Anton Lopez A, Ropo A. Efficacy, safety, and tolerability of preservative-free fixed combination of tafluprost 0.0015%/timolol 0.5% versus concomitant use of the ingredients. J Ocul Pharmacol Ther 2014;30:468-75. | 미소장 |
10 | Long term effect of latanoprost on intraocular pressure in normal tension glaucoma. ![]() |
미소장 |
11 | Comparison of Latanoprost and Timolol in Patients with Ocular Hypertension and Glaucoma: A Six-month, Masked, Multicenter Trial in the United States ![]() |
미소장 |
12 | Intraocular pressure control over 24 hours using travoprost and timolol fixed combination administered in the morning or evening in primary open-angle and exfoliative glaucoma. ![]() |
미소장 |
13 | Twenty-four-hour intraocular pressure control with bimatoprost and the bimatoprost/timolol fixed combination administered in the morning, or evening in exfoliative glaucoma. ![]() |
미소장 |
14 | Posture-induced Intraocular Pressure Changes: Considerations Regarding Body Position in Glaucoma Patients ![]() |
미소장 |
15 | Comparison of Intraocular Pressures According to Position Using Icare Rebound Tonometer | 소장 |
16 | Positional Change of Intraocular Pressure and Its Relationship to Ocular Pulse Amplitude | 소장 |
17 | Using diurnal intraocular pressure fluctuation to assess the efficacy of fixed-combination latanoprost/timolol versus latanoprost or timolol monotherapy. ![]() |
미소장 |
18 | Goldmann tonometer error correcting prism: clinical evaluation. ![]() |
미소장 |
19 | Control of Intraocular Pressure and Fluctuation With Fixed-Combination Brimonidine–Timolol Versus Brimonidine or Timolol Monotherapy ![]() |
미소장 |
20 | Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. ![]() |
미소장 |
21 | Efficacy and safety of tafluprost in normal-tension glaucoma with intraocular pressure of 16 mmHg or less ![]() |
미소장 |
22 | Timolol ![]() |
미소장 |
23 | The uniocular therapeutic trial in the management of elevated intraocular pressure ![]() |
미소장 |
24 | Bilateral Effects of Long-Term Monocular Timolol Therapy ![]() |
미소장 |
25 | The Glaucoma Laser Trial: 4. Contralateral effects of timolol on the intraocular pressure of eyes treated with ALT. GLT Research Group. ![]() |
미소장 |
26 | Martin XD, Rabineau PA. Intraocular pressure effects of timolol after unilateral instillation. Ophthalmology 1988;95:1620-3. | 미소장 |
27 | Contralateral effect of topical beta-adrenergic antagonists in initial one-eyed trials in the ocular hypertension treatment study. ![]() |
미소장 |
28 | Takagi Y, Osaki H, Yamashita T, Kai Y. Prospective observational post-marketing study of tafluprost 0.0015%/timolol 0.5% combination ophthalmic solution for glaucoma and ocular hypertension: short-term efficacy and safety. Ophthalmol Ther 2016;5:191-206. | 미소장 |
*표시는 필수 입력사항입니다.
*전화번호 | ※ '-' 없이 휴대폰번호를 입력하세요 |
---|
기사명 | 저자명 | 페이지 | 원문 | 기사목차 |
---|
번호 | 발행일자 | 권호명 | 제본정보 | 자료실 | 원문 | 신청 페이지 |
---|
도서위치안내: 정기간행물실(524호) / 서가번호: 국내03
2021년 이전 정기간행물은 온라인 신청(원문 구축 자료는 원문 이용)
우편복사 목록담기를 완료하였습니다.
*표시는 필수 입력사항입니다.
저장 되었습니다.